XML 36 R24.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Other income: | 9 Months Ended
--- | ---
Sep. 30, 2018
Other income: | NOTE 18 – Other income:
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017 |
|  | (U.S. $ in millions) |  |  | (U.S. $ in millions) |
Gain on divestitures, net of divestitures related costs (1) |  | $ | 31 |  |  |  | — |  |  | $ | 114 |  |  |  | — |
Section 8 and similar payments (2) |  |  | 1 |  |  |  | — |  |  |  | 195 |  |  |  | 83 |
Gain on sale of assets |  |  | 1 |  |  |  | — |  |  |  | 9 |  |  |  | — |
Other, net |  |  | 2 |  |  |  | 4 |  |  |  | 16 |  |  |  | 17 |
Total other income |  | $ | 35 |  |  | $ | 4 |  |  | $ | 334 |  |  | $ | 100 |
(1) | Mainly related to the divestment of the women’s health business and the PGT dissolution in 2018. See note 3.
(2) | Section 8 of the Patented Medicines (Notice of Compliance) Regulation relates to recoveries of lost revenue related to patent infringement proceedings in Canada.

X
- Definition The entire disclosure for other operating income and other operating expense items. + References No definition available. + Details
Name: | us-gaap_OtherOperatingIncomeAndExpenseTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration